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Editorial
The Permanent Challenge of Treating Diabetic Patients 
with Complex Coronary Artery Disease 
Áurea J. Chaves
D iabetes mellitus is a known factor that influences coronary artery bypass graft (CABG) surgery effectiveness. Selecting the most appropriate 
intervention, whether surgical or percutaneous, is es-
sential to provide the best care for patients with mul-
tivessel coronary disease. Since the mid-1990s, with 
the publication of the BARI trial results, diabetes has 
become an important variable to be considered in the 
decision-making of clinicians, interventional physicians, 
and cardiac surgeons. Recently, we have witnessed a 
series of studies comparing surgical procedures with 
more contemporary percutaneous interventions, whose 
results indicated comparable mortality between the two 
strategies. The results of the most recent studies, which 
employ drug-eluting stents, have been regarded with 
caution, as the data are derived from randomized trials 
without statistical power or subgroup analysis.
The randomized trial FREEDOM, with 1,900 pa-
tients, presented in November 2012 at the Scientific 
Sessions of American Heart Association, was designed 
to answer the question of which revascularization 
strategy would be the best in diabetic patients with 
complex multivessel disease. The trial’s long-awaited 
results are discussed in depth in an editorial by Cente-
mero, Abizaid, and Sousa, of Instituto Dante Pazzanese 
de Cardiologia (São Paulo, SP, Brazil). The authors 
highlight the many virtues of this study, as well as its 
limitations, and conclude by reinforcing the need to 
individualize decisions, and for the “heart team” to 
discuss therapeutic possibilities, involving the patient 
and family in the final decision.
This edition of Revista Brasileira de Cardiologia 
Invasiva (RBCI) presents numerous studies that address 
issues of significant current interest. Costa Jr. et al., 
from Hospital do Coração da Associação do Sanatório 
Sírio (São Paulo, SP, Brazil), present another contri-
bution from the DESIRE registry, this time evaluating 
the changes occurring in the last ten years regard-
ing the indication and performance of percutaneous 
coronary intervention (PCI) with drug-eluting stents. 
The authors describe the evolution of PCI as the 
prevalent mode of revascularization compared with 
surgery at that institution; the diffusion of drug-eluting 
stents, which reached almost 90% of the procedures 
last year; the increasing angiographic complexity 
evaluated by the SYNTAX score; and the good clinical 
outcomes in the five-year follow-up of over 98% of 
that population. 
Andrade et al., from Santa Casa de Marília (Marília, 
SP, Brazil), address the issue of inter-hospital transfer 
for primary PCI in their city, which has an integrated 
and efficient healthcare system for cardiovascular 
emergencies. The authors evaluate the efficacy and the 
safety outcomes of patients admitted or transferred to 
undergo the procedure. The researchers complement 
their analysis with very up-to-date discussions of the 
matter, addressing the issue of patient transfer in Brazil, 
which experiences the well-known problems related to 
urban traffic. 
Aguiar Filho et al., from Instituto Dante Pazzanese 
de Cardiologia, address the incorporation of transra-
dial PCI into their center, which is known for training 
interventional cardiologists. The authors demonstrate 
the increasingly frequent use of this access route over 
the last few years compared to the traditional femoral 
approach, and report the profiles of selected patients. 
The researchers demonstrate that the clinical outcomes 
can be similar to the outcomes in the literature, even 
when these procedures are performed by physicians in 
training, supervised by the interventional cardiologists 
in charge. 
Farinazzo et al., from Hospital Bandeirantes (São 
Paulo, SP, Brazil), explore the results of ad hoc PCI, a 
subject that is rarely explored in the Brazilian literature, 
in a large registry from that institution. The authors 
report the percentage of the population that underwent 
this intervention; the method’s clinical, angiographic, 
and procedural characterization; and in-hospital clinical 
outcomes compared with the outcomes in patients who 
underwent scheduled interventions. In their discussion, 
the researchers recall the limits of the indication of 
ad hoc PCI, according to the recent publication of a 
consensus by Society for Cardiovascular Angiography 
and Interventions (SCAI).
Finally, this issue includes original articles addressing 
topics such as PCI with same-day discharge; the results 
of PCI in patients with acute coronary syndromes who 
are submitted to low molecular-weight and unfractio-
nated heparin crossover; the predictors of bare-metal 
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stent thrombosis; the profiles and outcomes of patients 
undergoing PCI subsidized by the Brazilian Unified 
Health System (Sistema Único de Saúde – SUS) or by 
private health care; Doppler evaluation of radial artery 
patency in patients using this access route for coronary 
procedures; the profile of diagnostic and therapeutic 
percutaneous procedures in congenital heart disease at 
Instituto de Cardiologia do Rio Grande do Sul (Porto 
Alegre, RS, Brazil); and an experimental study that 
compares the quality of intimal hyperplasia, assessed 
by optical coherence tomography, of two drug-eluting 
stents with bioabsorbable polymers. 
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